Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nagamine Medical Clinic Ginza is a specialized medical facility located in Tokyo, Japan, focusing on advanced regenerative medicine and cancer immunotherapy. The clinic provides autologous adipose-derived stem cell therapies for various conditions, including osteoarthritis and anti-aging treatments. Additionally, it offers immune cell therapies such as NK cell and dendritic cell treatments aimed at supporting cancer patients. Led by Director Yoshikazu Nagamine, the clinic operates under Japan's Act on the Safety of Regenerative Medicine to ensure high standards of patient care and safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nagamine Medical Clinic Ginza.